DexCom, Inc. Stock price

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2023-12-01 pm EST Intraday chart for DexCom, Inc. 5-day change 1st Jan Change
116.62 USD +0.95% +3.25% +2.98%
Sales 2023 * 3,592 M Sales 2024 * 4,309 M Capitalization 45.06 B
Net income 2023 * 443 M Net income 2024 * 665 M EV / Sales 2023 *
13,0x
Net Debt 2023 * 1,790 M Net Debt 2024 * 1,107 M EV / Sales 2024 *
10,7x
P/E ratio 2023 *
108x
P/E ratio 2024 *
71,5x
Employees 7,550
Yield 2023 *
-
Yield 2024 *
-
Free-Float 94.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.95%
1 week+3.25%
Current month+0.95%
1 month+24.50%
3 months+14.45%
6 months-4.85%
Current year+2.98%
More quotes
1 week
111.29
Extreme 111.29
117.50
1 month
91.49
Extreme 91.485
117.50
Current year
74.75
Extreme 74.75
139.55
1 year
74.75
Extreme 74.75
139.55
3 years
66.89
Extreme 66.8925
164.86
5 years
26.26
Extreme 26.2625
164.86
10 years
7.02
Extreme 7.0225
164.86
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 2007
Director of Finance/CFO 43 2018
Chief Tech/Sci/R&D Officer 46 2022
Members of the board TitleAgeSince
Director/Board Member 62 2014
Director/Board Member 68 2009
Chief Executive Officer 65 2007
More insiders
Date Price Change Volume
23-12-01 116.62 +0.95% 3,075,029
23-11-30 115.52 -0.57% 4,537,499
23-11-29 116.18 +3.55% 4,734,844
23-11-28 112.20 -1.56% 4,492,399
23-11-27 113.98 +0.91% 3,687,258

Delayed Quote Nasdaq, December 01, 2023 at 04:00 pm EST

More quotes
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 73.6% of net sales.
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
116.62USD
Average target price
125.37USD
Spread / Average Target
+7.51%
Consensus
  1. Stock
  2. Equities
  3. Stock DexCom, Inc. - Nasdaq
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer